NASDAQ

Immunic, Inc. (IMUX)

♥ 537 Thanks from members

Live price chart, market sentiment, and community perspectives for Immunic, Inc. (NASDAQ: IMUX).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Thomas TauberFounder: Jürgen SindelarLeadership: Daniel Vitt (CEO)Leadership: Michael Scholl (CFO)Holder: Forbion Capital PartnersHolder: Omega FundsHolder: BVF PartnersVidofludimus Calcium (IMU-838)IMU-935IMU-856#IMUX#Immunic#Biotech#Autoimmune#Oral Therapies